Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: A pre-specified analysis from the EUROMAX trial
- Uwe Zeymer*
- , Arnoud Van't Hof
- , Jennifer Adgey
- , Lutz Nibbe
- , Peter Clemmensen
- , Claudio Cavallini
- , Jurrien Ten Berg
- , Pierre Coste
- , Kurt Huber
- , Efthymios N. Deliargyris
- , Jonathan Day
- , Debra Bernstein
- , Patrick Goldstein
- , Christian Hamm
- , Philippe Gabriel Steg
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review